Luligee Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class. It is indicated for the treatment of superficial fungal infections of the skin caused by dermatophytes, yeasts, and molds, including tinea corporis, tinea cruris, tinea pedis, and candidiasis. Luliconazole exerts its antifungal effect by inhibiting the enzyme lanosterol 14α-demethylase, which is essential for ergosterol synthesis, a critical component of fungal cell membranes. This inhibition results in increased membrane permeability and ultimately fungal cell death. Luligee Cream is applied topically once daily to the affected area and surrounding skin, typically for a duration of 2 to 4 weeks depending on the severity and type of infection. The cream is well tolerated, with minimal adverse effects such as mild burning, itching, or irritation at the application site. It is contraindicated in patients with known hypersensitivity to luliconazole or any component of the formulation. Caution is advised when applying to large areas or broken skin. Luligee Cream offers an effective and convenient treatment option for superficial fungal infections, promoting rapid symptom resolution and preventing recurrence when used as directed.